Lancashire and South Cumbria
Formulary
Formulary
4 Central nervous system
04-10-03 Opioid dependence
Links
MHRA Drug Safety Update Jan 2020: E-cigarette use or vaping: reporting suspected adverse reactions, including lung injury- NICE CG52: Drug misuse in over 16s: opioid detoxification
- NICE NG209: Tobacco: preventing uptake, promoting quitting and treating dependence
- NICE TA114: Methadone and buprenorphine for the management of opioid dependence
- NICE TA114: Methadone and buprenorphine for the management of opioid dependence
- NICE TA115: Drug misuse - naltrexone
- NICE TA115: Naltrexone for the management of opioid dependence